Omalizumab treatment associated with Churg-Strauss vasculitis.
Bargagli
Elena
E
Rottoli
Paola
P
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy; D015267:Churg-Strauss Syndrome / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D006889:Hydroxycorticosteroids / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006889:Hydroxycorticosteroids; D000069444:Omalizumab